drugset / Trial / NCT03153137
Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective is to assess the effect of macitentan 10 mg as compared to placebo on exercise capacity through cardiopulmonary exercise testing.
Timeline
- Start
- 2017-08-14
- Primary completion
- 2021-06-30
- Completion
- 2021-07-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Macitentan | Other / unclassified | 10 mg | Oral |